Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 73,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'catslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 73,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [
			[maximum depth reached]
		]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'latest-news-updates/cheap-medicine-myth-busted-gs-mudur-24447/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/latest-news-updates/cheap-medicine-myth-busted-gs-mudur-24447/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'catslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 73
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 74,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'artileslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 74,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [
			[maximum depth reached]
		]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'latest-news-updates/cheap-medicine-myth-busted-gs-mudur-24447/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/latest-news-updates/cheap-medicine-myth-busted-gs-mudur-24447/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'artileslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 74
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Warning (512): Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853 [CORE/src/Http/ResponseEmitter.php, line 48]
Code Context
            if (Configure::read('debug')) {

                trigger_error($message, E_USER_WARNING);

            } else {
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f319bab2668-trace').style.display = (document.getElementById('cakeErr67f319bab2668-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67f319bab2668-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f319bab2668-code').style.display = (document.getElementById('cakeErr67f319bab2668-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f319bab2668-context').style.display = (document.getElementById('cakeErr67f319bab2668-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67f319bab2668-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67f319bab2668-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 24268,
		&#039;title&#039; =&gt; &#039;Cheap medicine myth busted -GS Mudur&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Telegraph
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;br /&gt;
&lt;em&gt;New Delhi: &lt;/em&gt;The rules for price caps on 348 medicines imposed by the central government last year provide drug companies &amp;quot;escape routes&amp;quot; and promise little relief to consumers, a report released today has warned.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The report from the Public Health Foundation of India (PHFI), an academic institution, has also cautioned that the Drug Price Control Order (DPCO) rules will encourage the growth of irrational combinations of drugs that remain outside price control.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
PHFI researchers had in November last year presented preliminary results of their study at a conference, indicating that the DPCO covers drugs that account for only 17 per cent of the annual domestic sales worth Rs 72,000 crore.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The new report, described as a comprehensive analysis of the DPCO, has estimated that absolute decrease in the money spent on drugs in India is less than 2 per cent of baseline sales before the price caps came into effect.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;The price control rules do not seem to be the result of genuine intentions to provide relief to consumers,&amp;quot; said Malini Aisola, a research associate and health policy analyst at the PHFI, and one of the authors of the report.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The PHFI analysis has found that 18 of the top 20 new drug formulations - ranging from anti-diabetes and anti-cancer medications to vitamins - introduced by pharmaceutical companies in India over the past two years are outside price control.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The top-selling new brand, based on 2013 data from the pharmaceuticals industry, was a fixed dose combination of sitagliptin and metformin, used to treat diabetes, but outside price control. Examples of other drugs outside price control are those used to treat cancers, formulations containing vitamin D and calcium, a drug used to treat skin warts and drugs against HIV.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;We expect this trend to only grow - companies are likely to migrate to formulations not covered by the DPCO,&amp;quot; Aisola said. &amp;quot;The meagre 2 per cent relief that consumers seem to be getting now could shrink even more.&amp;quot;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
A network of health activists called the All India Drug Action Network has challenged the DPCO in the Supreme Court, contending that price caps should be imposed by taking into account the actual production costs of drugs instead of market prices as the DPCO does.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Sections of the pharmaceutical industry and government officials favouring the current form of the DPCO had said in the past that a shift to price caps based on actual production costs would hurt the pharmaceutical industry.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The PHFI report has also cautioned that the DPCO &amp;quot;paradoxically&amp;quot; punishes drug companies that have priced their products below price caps by forcing them to freeze their prices.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;This seems designed to kill the small and medium pharma industry,&amp;quot; said Aisola. &amp;quot;These rules punish those who charge less than the ceiling prices. Small companies often don&#039;t have deep pockets and could be badly hurt by increases in raw material prices or currency fluctuations.&amp;quot;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;There is nothing surprising,&amp;quot; said Chandra Gulhati, editor of the Monthly Index of Medical Specialities, India. &amp;quot;But I don&#039;t think the report&#039;s release has been timed well,&amp;quot; said Gulhati. &amp;quot;Who in the government is going to listen to this at this point of time?&amp;quot; 
&lt;/p&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Telegraph, 7 March, 2014, http://www.telegraphindia.com/1140307/jsp/frontpage/story_18054877.jsp#.Uxkpwc5fQrY&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;cheap-medicine-myth-busted-gs-mudur-24447&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 24447,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 24268,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | Cheap medicine myth busted -GS Mudur&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;medicines,Public Health,Health&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Telegraph



New Delhi: The rules for price caps on 348 medicines imposed by the central government last year provide drug companies &amp;quot;escape routes&amp;quot; and promise little relief to consumers, a report released today has warned.


The report from the Public Health...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-The Telegraph&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;br /&gt;&lt;em&gt;New Delhi: &lt;/em&gt;The rules for price caps on 348 medicines imposed by the central government last year provide drug companies &amp;quot;escape routes&amp;quot; and promise little relief to consumers, a report released today has warned.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The report from the Public Health Foundation of India (PHFI), an academic institution, has also cautioned that the Drug Price Control Order (DPCO) rules will encourage the growth of irrational combinations of drugs that remain outside price control.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;PHFI researchers had in November last year presented preliminary results of their study at a conference, indicating that the DPCO covers drugs that account for only 17 per cent of the annual domestic sales worth Rs 72,000 crore.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The new report, described as a comprehensive analysis of the DPCO, has estimated that absolute decrease in the money spent on drugs in India is less than 2 per cent of baseline sales before the price caps came into effect.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;The price control rules do not seem to be the result of genuine intentions to provide relief to consumers,&amp;quot; said Malini Aisola, a research associate and health policy analyst at the PHFI, and one of the authors of the report.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The PHFI analysis has found that 18 of the top 20 new drug formulations - ranging from anti-diabetes and anti-cancer medications to vitamins - introduced by pharmaceutical companies in India over the past two years are outside price control.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The top-selling new brand, based on 2013 data from the pharmaceuticals industry, was a fixed dose combination of sitagliptin and metformin, used to treat diabetes, but outside price control. Examples of other drugs outside price control are those used to treat cancers, formulations containing vitamin D and calcium, a drug used to treat skin warts and drugs against HIV.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;We expect this trend to only grow - companies are likely to migrate to formulations not covered by the DPCO,&amp;quot; Aisola said. &amp;quot;The meagre 2 per cent relief that consumers seem to be getting now could shrink even more.&amp;quot;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;A network of health activists called the All India Drug Action Network has challenged the DPCO in the Supreme Court, contending that price caps should be imposed by taking into account the actual production costs of drugs instead of market prices as the DPCO does.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Sections of the pharmaceutical industry and government officials favouring the current form of the DPCO had said in the past that a shift to price caps based on actual production costs would hurt the pharmaceutical industry.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The PHFI report has also cautioned that the DPCO &amp;quot;paradoxically&amp;quot; punishes drug companies that have priced their products below price caps by forcing them to freeze their prices.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;This seems designed to kill the small and medium pharma industry,&amp;quot; said Aisola. &amp;quot;These rules punish those who charge less than the ceiling prices. Small companies often don&#039;t have deep pockets and could be badly hurt by increases in raw material prices or currency fluctuations.&amp;quot;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;There is nothing surprising,&amp;quot; said Chandra Gulhati, editor of the Monthly Index of Medical Specialities, India. &amp;quot;But I don&#039;t think the report&#039;s release has been timed well,&amp;quot; said Gulhati. &amp;quot;Who in the government is going to listen to this at this point of time?&amp;quot; &lt;/p&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 24268,
	&#039;title&#039; =&gt; &#039;Cheap medicine myth busted -GS Mudur&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Telegraph
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;br /&gt;
&lt;em&gt;New Delhi: &lt;/em&gt;The rules for price caps on 348 medicines imposed by the central government last year provide drug companies &amp;quot;escape routes&amp;quot; and promise little relief to consumers, a report released today has warned.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The report from the Public Health Foundation of India (PHFI), an academic institution, has also cautioned that the Drug Price Control Order (DPCO) rules will encourage the growth of irrational combinations of drugs that remain outside price control.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
PHFI researchers had in November last year presented preliminary results of their study at a conference, indicating that the DPCO covers drugs that account for only 17 per cent of the annual domestic sales worth Rs 72,000 crore.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The new report, described as a comprehensive analysis of the DPCO, has estimated that absolute decrease in the money spent on drugs in India is less than 2 per cent of baseline sales before the price caps came into effect.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;The price control rules do not seem to be the result of genuine intentions to provide relief to consumers,&amp;quot; said Malini Aisola, a research associate and health policy analyst at the PHFI, and one of the authors of the report.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The PHFI analysis has found that 18 of the top 20 new drug formulations - ranging from anti-diabetes and anti-cancer medications to vitamins - introduced by pharmaceutical companies in India over the past two years are outside price control.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The top-selling new brand, based on 2013 data from the pharmaceuticals industry, was a fixed dose combination of sitagliptin and metformin, used to treat diabetes, but outside price control. Examples of other drugs outside price control are those used to treat cancers, formulations containing vitamin D and calcium, a drug used to treat skin warts and drugs against HIV.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;We expect this trend to only grow - companies are likely to migrate to formulations not covered by the DPCO,&amp;quot; Aisola said. &amp;quot;The meagre 2 per cent relief that consumers seem to be getting now could shrink even more.&amp;quot;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
A network of health activists called the All India Drug Action Network has challenged the DPCO in the Supreme Court, contending that price caps should be imposed by taking into account the actual production costs of drugs instead of market prices as the DPCO does.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Sections of the pharmaceutical industry and government officials favouring the current form of the DPCO had said in the past that a shift to price caps based on actual production costs would hurt the pharmaceutical industry.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The PHFI report has also cautioned that the DPCO &amp;quot;paradoxically&amp;quot; punishes drug companies that have priced their products below price caps by forcing them to freeze their prices.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;This seems designed to kill the small and medium pharma industry,&amp;quot; said Aisola. &amp;quot;These rules punish those who charge less than the ceiling prices. Small companies often don&#039;t have deep pockets and could be badly hurt by increases in raw material prices or currency fluctuations.&amp;quot;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;There is nothing surprising,&amp;quot; said Chandra Gulhati, editor of the Monthly Index of Medical Specialities, India. &amp;quot;But I don&#039;t think the report&#039;s release has been timed well,&amp;quot; said Gulhati. &amp;quot;Who in the government is going to listen to this at this point of time?&amp;quot; 
&lt;/p&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Telegraph, 7 March, 2014, http://www.telegraphindia.com/1140307/jsp/frontpage/story_18054877.jsp#.Uxkpwc5fQrY&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;cheap-medicine-myth-busted-gs-mudur-24447&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 24447,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 24268
$metaTitle = &#039;LATEST NEWS UPDATES | Cheap medicine myth busted -GS Mudur&#039;
$metaKeywords = &#039;medicines,Public Health,Health&#039;
$metaDesc = &#039;
-The Telegraph



New Delhi: The rules for price caps on 348 medicines imposed by the central government last year provide drug companies &amp;quot;escape routes&amp;quot; and promise little relief to consumers, a report released today has warned.


The report from the Public Health...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-The Telegraph&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;br /&gt;&lt;em&gt;New Delhi: &lt;/em&gt;The rules for price caps on 348 medicines imposed by the central government last year provide drug companies &amp;quot;escape routes&amp;quot; and promise little relief to consumers, a report released today has warned.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The report from the Public Health Foundation of India (PHFI), an academic institution, has also cautioned that the Drug Price Control Order (DPCO) rules will encourage the growth of irrational combinations of drugs that remain outside price control.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;PHFI researchers had in November last year presented preliminary results of their study at a conference, indicating that the DPCO covers drugs that account for only 17 per cent of the annual domestic sales worth Rs 72,000 crore.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The new report, described as a comprehensive analysis of the DPCO, has estimated that absolute decrease in the money spent on drugs in India is less than 2 per cent of baseline sales before the price caps came into effect.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;The price control rules do not seem to be the result of genuine intentions to provide relief to consumers,&amp;quot; said Malini Aisola, a research associate and health policy analyst at the PHFI, and one of the authors of the report.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The PHFI analysis has found that 18 of the top 20 new drug formulations - ranging from anti-diabetes and anti-cancer medications to vitamins - introduced by pharmaceutical companies in India over the past two years are outside price control.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The top-selling new brand, based on 2013 data from the pharmaceuticals industry, was a fixed dose combination of sitagliptin and metformin, used to treat diabetes, but outside price control. Examples of other drugs outside price control are those used to treat cancers, formulations containing vitamin D and calcium, a drug used to treat skin warts and drugs against HIV.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;We expect this trend to only grow - companies are likely to migrate to formulations not covered by the DPCO,&amp;quot; Aisola said. &amp;quot;The meagre 2 per cent relief that consumers seem to be getting now could shrink even more.&amp;quot;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;A network of health activists called the All India Drug Action Network has challenged the DPCO in the Supreme Court, contending that price caps should be imposed by taking into account the actual production costs of drugs instead of market prices as the DPCO does.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Sections of the pharmaceutical industry and government officials favouring the current form of the DPCO had said in the past that a shift to price caps based on actual production costs would hurt the pharmaceutical industry.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The PHFI report has also cautioned that the DPCO &amp;quot;paradoxically&amp;quot; punishes drug companies that have priced their products below price caps by forcing them to freeze their prices.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;This seems designed to kill the small and medium pharma industry,&amp;quot; said Aisola. &amp;quot;These rules punish those who charge less than the ceiling prices. Small companies often don&#039;t have deep pockets and could be badly hurt by increases in raw material prices or currency fluctuations.&amp;quot;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;There is nothing surprising,&amp;quot; said Chandra Gulhati, editor of the Monthly Index of Medical Specialities, India. &amp;quot;But I don&#039;t think the report&#039;s release has been timed well,&amp;quot; said Gulhati. &amp;quot;Who in the government is going to listen to this at this point of time?&amp;quot; &lt;/p&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/cheap-medicine-myth-busted-gs-mudur-24447.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | Cheap medicine myth busted -GS Mudur | Im4change.org</title>
    <meta name="description" content="
-The Telegraph



New Delhi: The rules for price caps on 348 medicines imposed by the central government last year provide drug companies &quot;escape routes&quot; and promise little relief to consumers, a report released today has warned.


The report from the Public Health..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>Cheap medicine myth busted -GS Mudur</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-The Telegraph</div><p align="justify"><br /><em>New Delhi: </em>The rules for price caps on 348 medicines imposed by the central government last year provide drug companies &quot;escape routes&quot; and promise little relief to consumers, a report released today has warned.</p><p align="justify">The report from the Public Health Foundation of India (PHFI), an academic institution, has also cautioned that the Drug Price Control Order (DPCO) rules will encourage the growth of irrational combinations of drugs that remain outside price control.</p><p align="justify">PHFI researchers had in November last year presented preliminary results of their study at a conference, indicating that the DPCO covers drugs that account for only 17 per cent of the annual domestic sales worth Rs 72,000 crore.</p><p align="justify">The new report, described as a comprehensive analysis of the DPCO, has estimated that absolute decrease in the money spent on drugs in India is less than 2 per cent of baseline sales before the price caps came into effect.</p><p align="justify">&quot;The price control rules do not seem to be the result of genuine intentions to provide relief to consumers,&quot; said Malini Aisola, a research associate and health policy analyst at the PHFI, and one of the authors of the report.</p><p align="justify">The PHFI analysis has found that 18 of the top 20 new drug formulations - ranging from anti-diabetes and anti-cancer medications to vitamins - introduced by pharmaceutical companies in India over the past two years are outside price control.</p><p align="justify">The top-selling new brand, based on 2013 data from the pharmaceuticals industry, was a fixed dose combination of sitagliptin and metformin, used to treat diabetes, but outside price control. Examples of other drugs outside price control are those used to treat cancers, formulations containing vitamin D and calcium, a drug used to treat skin warts and drugs against HIV.</p><p align="justify">&quot;We expect this trend to only grow - companies are likely to migrate to formulations not covered by the DPCO,&quot; Aisola said. &quot;The meagre 2 per cent relief that consumers seem to be getting now could shrink even more.&quot;</p><p align="justify">A network of health activists called the All India Drug Action Network has challenged the DPCO in the Supreme Court, contending that price caps should be imposed by taking into account the actual production costs of drugs instead of market prices as the DPCO does.</p><p align="justify">Sections of the pharmaceutical industry and government officials favouring the current form of the DPCO had said in the past that a shift to price caps based on actual production costs would hurt the pharmaceutical industry.</p><p align="justify">The PHFI report has also cautioned that the DPCO &quot;paradoxically&quot; punishes drug companies that have priced their products below price caps by forcing them to freeze their prices.</p><p align="justify">&quot;This seems designed to kill the small and medium pharma industry,&quot; said Aisola. &quot;These rules punish those who charge less than the ceiling prices. Small companies often don't have deep pockets and could be badly hurt by increases in raw material prices or currency fluctuations.&quot;</p><p align="justify">&quot;There is nothing surprising,&quot; said Chandra Gulhati, editor of the Monthly Index of Medical Specialities, India. &quot;But I don't think the report's release has been timed well,&quot; said Gulhati. &quot;Who in the government is going to listen to this at this point of time?&quot; </p>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$maxBufferLength = (int) 8192
$file = '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php'
$line = (int) 853
$message = 'Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853'
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 48
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 148]
Code Context
            $response->getStatusCode(),

            ($reasonPhrase ? ' ' . $reasonPhrase : '')

        ));
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f319bab2668-trace').style.display = (document.getElementById('cakeErr67f319bab2668-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67f319bab2668-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f319bab2668-code').style.display = (document.getElementById('cakeErr67f319bab2668-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f319bab2668-context').style.display = (document.getElementById('cakeErr67f319bab2668-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67f319bab2668-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67f319bab2668-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 24268,
		&#039;title&#039; =&gt; &#039;Cheap medicine myth busted -GS Mudur&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Telegraph
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;br /&gt;
&lt;em&gt;New Delhi: &lt;/em&gt;The rules for price caps on 348 medicines imposed by the central government last year provide drug companies &amp;quot;escape routes&amp;quot; and promise little relief to consumers, a report released today has warned.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The report from the Public Health Foundation of India (PHFI), an academic institution, has also cautioned that the Drug Price Control Order (DPCO) rules will encourage the growth of irrational combinations of drugs that remain outside price control.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
PHFI researchers had in November last year presented preliminary results of their study at a conference, indicating that the DPCO covers drugs that account for only 17 per cent of the annual domestic sales worth Rs 72,000 crore.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The new report, described as a comprehensive analysis of the DPCO, has estimated that absolute decrease in the money spent on drugs in India is less than 2 per cent of baseline sales before the price caps came into effect.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;The price control rules do not seem to be the result of genuine intentions to provide relief to consumers,&amp;quot; said Malini Aisola, a research associate and health policy analyst at the PHFI, and one of the authors of the report.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The PHFI analysis has found that 18 of the top 20 new drug formulations - ranging from anti-diabetes and anti-cancer medications to vitamins - introduced by pharmaceutical companies in India over the past two years are outside price control.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The top-selling new brand, based on 2013 data from the pharmaceuticals industry, was a fixed dose combination of sitagliptin and metformin, used to treat diabetes, but outside price control. Examples of other drugs outside price control are those used to treat cancers, formulations containing vitamin D and calcium, a drug used to treat skin warts and drugs against HIV.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;We expect this trend to only grow - companies are likely to migrate to formulations not covered by the DPCO,&amp;quot; Aisola said. &amp;quot;The meagre 2 per cent relief that consumers seem to be getting now could shrink even more.&amp;quot;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
A network of health activists called the All India Drug Action Network has challenged the DPCO in the Supreme Court, contending that price caps should be imposed by taking into account the actual production costs of drugs instead of market prices as the DPCO does.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Sections of the pharmaceutical industry and government officials favouring the current form of the DPCO had said in the past that a shift to price caps based on actual production costs would hurt the pharmaceutical industry.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The PHFI report has also cautioned that the DPCO &amp;quot;paradoxically&amp;quot; punishes drug companies that have priced their products below price caps by forcing them to freeze their prices.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;This seems designed to kill the small and medium pharma industry,&amp;quot; said Aisola. &amp;quot;These rules punish those who charge less than the ceiling prices. Small companies often don&#039;t have deep pockets and could be badly hurt by increases in raw material prices or currency fluctuations.&amp;quot;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;There is nothing surprising,&amp;quot; said Chandra Gulhati, editor of the Monthly Index of Medical Specialities, India. &amp;quot;But I don&#039;t think the report&#039;s release has been timed well,&amp;quot; said Gulhati. &amp;quot;Who in the government is going to listen to this at this point of time?&amp;quot; 
&lt;/p&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Telegraph, 7 March, 2014, http://www.telegraphindia.com/1140307/jsp/frontpage/story_18054877.jsp#.Uxkpwc5fQrY&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;cheap-medicine-myth-busted-gs-mudur-24447&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 24447,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 24268,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | Cheap medicine myth busted -GS Mudur&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;medicines,Public Health,Health&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Telegraph



New Delhi: The rules for price caps on 348 medicines imposed by the central government last year provide drug companies &amp;quot;escape routes&amp;quot; and promise little relief to consumers, a report released today has warned.


The report from the Public Health...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-The Telegraph&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;br /&gt;&lt;em&gt;New Delhi: &lt;/em&gt;The rules for price caps on 348 medicines imposed by the central government last year provide drug companies &amp;quot;escape routes&amp;quot; and promise little relief to consumers, a report released today has warned.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The report from the Public Health Foundation of India (PHFI), an academic institution, has also cautioned that the Drug Price Control Order (DPCO) rules will encourage the growth of irrational combinations of drugs that remain outside price control.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;PHFI researchers had in November last year presented preliminary results of their study at a conference, indicating that the DPCO covers drugs that account for only 17 per cent of the annual domestic sales worth Rs 72,000 crore.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The new report, described as a comprehensive analysis of the DPCO, has estimated that absolute decrease in the money spent on drugs in India is less than 2 per cent of baseline sales before the price caps came into effect.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;The price control rules do not seem to be the result of genuine intentions to provide relief to consumers,&amp;quot; said Malini Aisola, a research associate and health policy analyst at the PHFI, and one of the authors of the report.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The PHFI analysis has found that 18 of the top 20 new drug formulations - ranging from anti-diabetes and anti-cancer medications to vitamins - introduced by pharmaceutical companies in India over the past two years are outside price control.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The top-selling new brand, based on 2013 data from the pharmaceuticals industry, was a fixed dose combination of sitagliptin and metformin, used to treat diabetes, but outside price control. Examples of other drugs outside price control are those used to treat cancers, formulations containing vitamin D and calcium, a drug used to treat skin warts and drugs against HIV.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;We expect this trend to only grow - companies are likely to migrate to formulations not covered by the DPCO,&amp;quot; Aisola said. &amp;quot;The meagre 2 per cent relief that consumers seem to be getting now could shrink even more.&amp;quot;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;A network of health activists called the All India Drug Action Network has challenged the DPCO in the Supreme Court, contending that price caps should be imposed by taking into account the actual production costs of drugs instead of market prices as the DPCO does.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Sections of the pharmaceutical industry and government officials favouring the current form of the DPCO had said in the past that a shift to price caps based on actual production costs would hurt the pharmaceutical industry.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The PHFI report has also cautioned that the DPCO &amp;quot;paradoxically&amp;quot; punishes drug companies that have priced their products below price caps by forcing them to freeze their prices.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;This seems designed to kill the small and medium pharma industry,&amp;quot; said Aisola. &amp;quot;These rules punish those who charge less than the ceiling prices. Small companies often don&#039;t have deep pockets and could be badly hurt by increases in raw material prices or currency fluctuations.&amp;quot;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;There is nothing surprising,&amp;quot; said Chandra Gulhati, editor of the Monthly Index of Medical Specialities, India. &amp;quot;But I don&#039;t think the report&#039;s release has been timed well,&amp;quot; said Gulhati. &amp;quot;Who in the government is going to listen to this at this point of time?&amp;quot; &lt;/p&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 24268,
	&#039;title&#039; =&gt; &#039;Cheap medicine myth busted -GS Mudur&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Telegraph
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;br /&gt;
&lt;em&gt;New Delhi: &lt;/em&gt;The rules for price caps on 348 medicines imposed by the central government last year provide drug companies &amp;quot;escape routes&amp;quot; and promise little relief to consumers, a report released today has warned.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The report from the Public Health Foundation of India (PHFI), an academic institution, has also cautioned that the Drug Price Control Order (DPCO) rules will encourage the growth of irrational combinations of drugs that remain outside price control.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
PHFI researchers had in November last year presented preliminary results of their study at a conference, indicating that the DPCO covers drugs that account for only 17 per cent of the annual domestic sales worth Rs 72,000 crore.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The new report, described as a comprehensive analysis of the DPCO, has estimated that absolute decrease in the money spent on drugs in India is less than 2 per cent of baseline sales before the price caps came into effect.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;The price control rules do not seem to be the result of genuine intentions to provide relief to consumers,&amp;quot; said Malini Aisola, a research associate and health policy analyst at the PHFI, and one of the authors of the report.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The PHFI analysis has found that 18 of the top 20 new drug formulations - ranging from anti-diabetes and anti-cancer medications to vitamins - introduced by pharmaceutical companies in India over the past two years are outside price control.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The top-selling new brand, based on 2013 data from the pharmaceuticals industry, was a fixed dose combination of sitagliptin and metformin, used to treat diabetes, but outside price control. Examples of other drugs outside price control are those used to treat cancers, formulations containing vitamin D and calcium, a drug used to treat skin warts and drugs against HIV.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;We expect this trend to only grow - companies are likely to migrate to formulations not covered by the DPCO,&amp;quot; Aisola said. &amp;quot;The meagre 2 per cent relief that consumers seem to be getting now could shrink even more.&amp;quot;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
A network of health activists called the All India Drug Action Network has challenged the DPCO in the Supreme Court, contending that price caps should be imposed by taking into account the actual production costs of drugs instead of market prices as the DPCO does.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Sections of the pharmaceutical industry and government officials favouring the current form of the DPCO had said in the past that a shift to price caps based on actual production costs would hurt the pharmaceutical industry.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The PHFI report has also cautioned that the DPCO &amp;quot;paradoxically&amp;quot; punishes drug companies that have priced their products below price caps by forcing them to freeze their prices.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;This seems designed to kill the small and medium pharma industry,&amp;quot; said Aisola. &amp;quot;These rules punish those who charge less than the ceiling prices. Small companies often don&#039;t have deep pockets and could be badly hurt by increases in raw material prices or currency fluctuations.&amp;quot;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;There is nothing surprising,&amp;quot; said Chandra Gulhati, editor of the Monthly Index of Medical Specialities, India. &amp;quot;But I don&#039;t think the report&#039;s release has been timed well,&amp;quot; said Gulhati. &amp;quot;Who in the government is going to listen to this at this point of time?&amp;quot; 
&lt;/p&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Telegraph, 7 March, 2014, http://www.telegraphindia.com/1140307/jsp/frontpage/story_18054877.jsp#.Uxkpwc5fQrY&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;cheap-medicine-myth-busted-gs-mudur-24447&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 24447,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 24268
$metaTitle = &#039;LATEST NEWS UPDATES | Cheap medicine myth busted -GS Mudur&#039;
$metaKeywords = &#039;medicines,Public Health,Health&#039;
$metaDesc = &#039;
-The Telegraph



New Delhi: The rules for price caps on 348 medicines imposed by the central government last year provide drug companies &amp;quot;escape routes&amp;quot; and promise little relief to consumers, a report released today has warned.


The report from the Public Health...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-The Telegraph&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;br /&gt;&lt;em&gt;New Delhi: &lt;/em&gt;The rules for price caps on 348 medicines imposed by the central government last year provide drug companies &amp;quot;escape routes&amp;quot; and promise little relief to consumers, a report released today has warned.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The report from the Public Health Foundation of India (PHFI), an academic institution, has also cautioned that the Drug Price Control Order (DPCO) rules will encourage the growth of irrational combinations of drugs that remain outside price control.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;PHFI researchers had in November last year presented preliminary results of their study at a conference, indicating that the DPCO covers drugs that account for only 17 per cent of the annual domestic sales worth Rs 72,000 crore.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The new report, described as a comprehensive analysis of the DPCO, has estimated that absolute decrease in the money spent on drugs in India is less than 2 per cent of baseline sales before the price caps came into effect.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;The price control rules do not seem to be the result of genuine intentions to provide relief to consumers,&amp;quot; said Malini Aisola, a research associate and health policy analyst at the PHFI, and one of the authors of the report.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The PHFI analysis has found that 18 of the top 20 new drug formulations - ranging from anti-diabetes and anti-cancer medications to vitamins - introduced by pharmaceutical companies in India over the past two years are outside price control.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The top-selling new brand, based on 2013 data from the pharmaceuticals industry, was a fixed dose combination of sitagliptin and metformin, used to treat diabetes, but outside price control. Examples of other drugs outside price control are those used to treat cancers, formulations containing vitamin D and calcium, a drug used to treat skin warts and drugs against HIV.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;We expect this trend to only grow - companies are likely to migrate to formulations not covered by the DPCO,&amp;quot; Aisola said. &amp;quot;The meagre 2 per cent relief that consumers seem to be getting now could shrink even more.&amp;quot;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;A network of health activists called the All India Drug Action Network has challenged the DPCO in the Supreme Court, contending that price caps should be imposed by taking into account the actual production costs of drugs instead of market prices as the DPCO does.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Sections of the pharmaceutical industry and government officials favouring the current form of the DPCO had said in the past that a shift to price caps based on actual production costs would hurt the pharmaceutical industry.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The PHFI report has also cautioned that the DPCO &amp;quot;paradoxically&amp;quot; punishes drug companies that have priced their products below price caps by forcing them to freeze their prices.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;This seems designed to kill the small and medium pharma industry,&amp;quot; said Aisola. &amp;quot;These rules punish those who charge less than the ceiling prices. Small companies often don&#039;t have deep pockets and could be badly hurt by increases in raw material prices or currency fluctuations.&amp;quot;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;There is nothing surprising,&amp;quot; said Chandra Gulhati, editor of the Monthly Index of Medical Specialities, India. &amp;quot;But I don&#039;t think the report&#039;s release has been timed well,&amp;quot; said Gulhati. &amp;quot;Who in the government is going to listen to this at this point of time?&amp;quot; &lt;/p&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/cheap-medicine-myth-busted-gs-mudur-24447.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | Cheap medicine myth busted -GS Mudur | Im4change.org</title>
    <meta name="description" content="
-The Telegraph



New Delhi: The rules for price caps on 348 medicines imposed by the central government last year provide drug companies &quot;escape routes&quot; and promise little relief to consumers, a report released today has warned.


The report from the Public Health..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>Cheap medicine myth busted -GS Mudur</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-The Telegraph</div><p align="justify"><br /><em>New Delhi: </em>The rules for price caps on 348 medicines imposed by the central government last year provide drug companies &quot;escape routes&quot; and promise little relief to consumers, a report released today has warned.</p><p align="justify">The report from the Public Health Foundation of India (PHFI), an academic institution, has also cautioned that the Drug Price Control Order (DPCO) rules will encourage the growth of irrational combinations of drugs that remain outside price control.</p><p align="justify">PHFI researchers had in November last year presented preliminary results of their study at a conference, indicating that the DPCO covers drugs that account for only 17 per cent of the annual domestic sales worth Rs 72,000 crore.</p><p align="justify">The new report, described as a comprehensive analysis of the DPCO, has estimated that absolute decrease in the money spent on drugs in India is less than 2 per cent of baseline sales before the price caps came into effect.</p><p align="justify">&quot;The price control rules do not seem to be the result of genuine intentions to provide relief to consumers,&quot; said Malini Aisola, a research associate and health policy analyst at the PHFI, and one of the authors of the report.</p><p align="justify">The PHFI analysis has found that 18 of the top 20 new drug formulations - ranging from anti-diabetes and anti-cancer medications to vitamins - introduced by pharmaceutical companies in India over the past two years are outside price control.</p><p align="justify">The top-selling new brand, based on 2013 data from the pharmaceuticals industry, was a fixed dose combination of sitagliptin and metformin, used to treat diabetes, but outside price control. Examples of other drugs outside price control are those used to treat cancers, formulations containing vitamin D and calcium, a drug used to treat skin warts and drugs against HIV.</p><p align="justify">&quot;We expect this trend to only grow - companies are likely to migrate to formulations not covered by the DPCO,&quot; Aisola said. &quot;The meagre 2 per cent relief that consumers seem to be getting now could shrink even more.&quot;</p><p align="justify">A network of health activists called the All India Drug Action Network has challenged the DPCO in the Supreme Court, contending that price caps should be imposed by taking into account the actual production costs of drugs instead of market prices as the DPCO does.</p><p align="justify">Sections of the pharmaceutical industry and government officials favouring the current form of the DPCO had said in the past that a shift to price caps based on actual production costs would hurt the pharmaceutical industry.</p><p align="justify">The PHFI report has also cautioned that the DPCO &quot;paradoxically&quot; punishes drug companies that have priced their products below price caps by forcing them to freeze their prices.</p><p align="justify">&quot;This seems designed to kill the small and medium pharma industry,&quot; said Aisola. &quot;These rules punish those who charge less than the ceiling prices. Small companies often don't have deep pockets and could be badly hurt by increases in raw material prices or currency fluctuations.&quot;</p><p align="justify">&quot;There is nothing surprising,&quot; said Chandra Gulhati, editor of the Monthly Index of Medical Specialities, India. &quot;But I don't think the report's release has been timed well,&quot; said Gulhati. &quot;Who in the government is going to listen to this at this point of time?&quot; </p>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$reasonPhrase = 'OK'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitStatusLine() - CORE/src/Http/ResponseEmitter.php, line 148
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 54
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 181]
Code Context
                    $value

                ), $first);

                $first = false;
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f319bab2668-trace').style.display = (document.getElementById('cakeErr67f319bab2668-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67f319bab2668-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f319bab2668-code').style.display = (document.getElementById('cakeErr67f319bab2668-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f319bab2668-context').style.display = (document.getElementById('cakeErr67f319bab2668-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67f319bab2668-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67f319bab2668-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 24268,
		&#039;title&#039; =&gt; &#039;Cheap medicine myth busted -GS Mudur&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Telegraph
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;br /&gt;
&lt;em&gt;New Delhi: &lt;/em&gt;The rules for price caps on 348 medicines imposed by the central government last year provide drug companies &amp;quot;escape routes&amp;quot; and promise little relief to consumers, a report released today has warned.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The report from the Public Health Foundation of India (PHFI), an academic institution, has also cautioned that the Drug Price Control Order (DPCO) rules will encourage the growth of irrational combinations of drugs that remain outside price control.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
PHFI researchers had in November last year presented preliminary results of their study at a conference, indicating that the DPCO covers drugs that account for only 17 per cent of the annual domestic sales worth Rs 72,000 crore.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The new report, described as a comprehensive analysis of the DPCO, has estimated that absolute decrease in the money spent on drugs in India is less than 2 per cent of baseline sales before the price caps came into effect.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;The price control rules do not seem to be the result of genuine intentions to provide relief to consumers,&amp;quot; said Malini Aisola, a research associate and health policy analyst at the PHFI, and one of the authors of the report.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The PHFI analysis has found that 18 of the top 20 new drug formulations - ranging from anti-diabetes and anti-cancer medications to vitamins - introduced by pharmaceutical companies in India over the past two years are outside price control.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The top-selling new brand, based on 2013 data from the pharmaceuticals industry, was a fixed dose combination of sitagliptin and metformin, used to treat diabetes, but outside price control. Examples of other drugs outside price control are those used to treat cancers, formulations containing vitamin D and calcium, a drug used to treat skin warts and drugs against HIV.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;We expect this trend to only grow - companies are likely to migrate to formulations not covered by the DPCO,&amp;quot; Aisola said. &amp;quot;The meagre 2 per cent relief that consumers seem to be getting now could shrink even more.&amp;quot;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
A network of health activists called the All India Drug Action Network has challenged the DPCO in the Supreme Court, contending that price caps should be imposed by taking into account the actual production costs of drugs instead of market prices as the DPCO does.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Sections of the pharmaceutical industry and government officials favouring the current form of the DPCO had said in the past that a shift to price caps based on actual production costs would hurt the pharmaceutical industry.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The PHFI report has also cautioned that the DPCO &amp;quot;paradoxically&amp;quot; punishes drug companies that have priced their products below price caps by forcing them to freeze their prices.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;This seems designed to kill the small and medium pharma industry,&amp;quot; said Aisola. &amp;quot;These rules punish those who charge less than the ceiling prices. Small companies often don&#039;t have deep pockets and could be badly hurt by increases in raw material prices or currency fluctuations.&amp;quot;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;There is nothing surprising,&amp;quot; said Chandra Gulhati, editor of the Monthly Index of Medical Specialities, India. &amp;quot;But I don&#039;t think the report&#039;s release has been timed well,&amp;quot; said Gulhati. &amp;quot;Who in the government is going to listen to this at this point of time?&amp;quot; 
&lt;/p&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Telegraph, 7 March, 2014, http://www.telegraphindia.com/1140307/jsp/frontpage/story_18054877.jsp#.Uxkpwc5fQrY&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;cheap-medicine-myth-busted-gs-mudur-24447&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 24447,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 24268,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | Cheap medicine myth busted -GS Mudur&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;medicines,Public Health,Health&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Telegraph



New Delhi: The rules for price caps on 348 medicines imposed by the central government last year provide drug companies &amp;quot;escape routes&amp;quot; and promise little relief to consumers, a report released today has warned.


The report from the Public Health...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-The Telegraph&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;br /&gt;&lt;em&gt;New Delhi: &lt;/em&gt;The rules for price caps on 348 medicines imposed by the central government last year provide drug companies &amp;quot;escape routes&amp;quot; and promise little relief to consumers, a report released today has warned.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The report from the Public Health Foundation of India (PHFI), an academic institution, has also cautioned that the Drug Price Control Order (DPCO) rules will encourage the growth of irrational combinations of drugs that remain outside price control.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;PHFI researchers had in November last year presented preliminary results of their study at a conference, indicating that the DPCO covers drugs that account for only 17 per cent of the annual domestic sales worth Rs 72,000 crore.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The new report, described as a comprehensive analysis of the DPCO, has estimated that absolute decrease in the money spent on drugs in India is less than 2 per cent of baseline sales before the price caps came into effect.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;The price control rules do not seem to be the result of genuine intentions to provide relief to consumers,&amp;quot; said Malini Aisola, a research associate and health policy analyst at the PHFI, and one of the authors of the report.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The PHFI analysis has found that 18 of the top 20 new drug formulations - ranging from anti-diabetes and anti-cancer medications to vitamins - introduced by pharmaceutical companies in India over the past two years are outside price control.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The top-selling new brand, based on 2013 data from the pharmaceuticals industry, was a fixed dose combination of sitagliptin and metformin, used to treat diabetes, but outside price control. Examples of other drugs outside price control are those used to treat cancers, formulations containing vitamin D and calcium, a drug used to treat skin warts and drugs against HIV.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;We expect this trend to only grow - companies are likely to migrate to formulations not covered by the DPCO,&amp;quot; Aisola said. &amp;quot;The meagre 2 per cent relief that consumers seem to be getting now could shrink even more.&amp;quot;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;A network of health activists called the All India Drug Action Network has challenged the DPCO in the Supreme Court, contending that price caps should be imposed by taking into account the actual production costs of drugs instead of market prices as the DPCO does.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Sections of the pharmaceutical industry and government officials favouring the current form of the DPCO had said in the past that a shift to price caps based on actual production costs would hurt the pharmaceutical industry.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The PHFI report has also cautioned that the DPCO &amp;quot;paradoxically&amp;quot; punishes drug companies that have priced their products below price caps by forcing them to freeze their prices.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;This seems designed to kill the small and medium pharma industry,&amp;quot; said Aisola. &amp;quot;These rules punish those who charge less than the ceiling prices. Small companies often don&#039;t have deep pockets and could be badly hurt by increases in raw material prices or currency fluctuations.&amp;quot;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;There is nothing surprising,&amp;quot; said Chandra Gulhati, editor of the Monthly Index of Medical Specialities, India. &amp;quot;But I don&#039;t think the report&#039;s release has been timed well,&amp;quot; said Gulhati. &amp;quot;Who in the government is going to listen to this at this point of time?&amp;quot; &lt;/p&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 24268,
	&#039;title&#039; =&gt; &#039;Cheap medicine myth busted -GS Mudur&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Telegraph
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;br /&gt;
&lt;em&gt;New Delhi: &lt;/em&gt;The rules for price caps on 348 medicines imposed by the central government last year provide drug companies &amp;quot;escape routes&amp;quot; and promise little relief to consumers, a report released today has warned.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The report from the Public Health Foundation of India (PHFI), an academic institution, has also cautioned that the Drug Price Control Order (DPCO) rules will encourage the growth of irrational combinations of drugs that remain outside price control.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
PHFI researchers had in November last year presented preliminary results of their study at a conference, indicating that the DPCO covers drugs that account for only 17 per cent of the annual domestic sales worth Rs 72,000 crore.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The new report, described as a comprehensive analysis of the DPCO, has estimated that absolute decrease in the money spent on drugs in India is less than 2 per cent of baseline sales before the price caps came into effect.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;The price control rules do not seem to be the result of genuine intentions to provide relief to consumers,&amp;quot; said Malini Aisola, a research associate and health policy analyst at the PHFI, and one of the authors of the report.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The PHFI analysis has found that 18 of the top 20 new drug formulations - ranging from anti-diabetes and anti-cancer medications to vitamins - introduced by pharmaceutical companies in India over the past two years are outside price control.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The top-selling new brand, based on 2013 data from the pharmaceuticals industry, was a fixed dose combination of sitagliptin and metformin, used to treat diabetes, but outside price control. Examples of other drugs outside price control are those used to treat cancers, formulations containing vitamin D and calcium, a drug used to treat skin warts and drugs against HIV.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;We expect this trend to only grow - companies are likely to migrate to formulations not covered by the DPCO,&amp;quot; Aisola said. &amp;quot;The meagre 2 per cent relief that consumers seem to be getting now could shrink even more.&amp;quot;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
A network of health activists called the All India Drug Action Network has challenged the DPCO in the Supreme Court, contending that price caps should be imposed by taking into account the actual production costs of drugs instead of market prices as the DPCO does.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Sections of the pharmaceutical industry and government officials favouring the current form of the DPCO had said in the past that a shift to price caps based on actual production costs would hurt the pharmaceutical industry.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The PHFI report has also cautioned that the DPCO &amp;quot;paradoxically&amp;quot; punishes drug companies that have priced their products below price caps by forcing them to freeze their prices.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;This seems designed to kill the small and medium pharma industry,&amp;quot; said Aisola. &amp;quot;These rules punish those who charge less than the ceiling prices. Small companies often don&#039;t have deep pockets and could be badly hurt by increases in raw material prices or currency fluctuations.&amp;quot;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;There is nothing surprising,&amp;quot; said Chandra Gulhati, editor of the Monthly Index of Medical Specialities, India. &amp;quot;But I don&#039;t think the report&#039;s release has been timed well,&amp;quot; said Gulhati. &amp;quot;Who in the government is going to listen to this at this point of time?&amp;quot; 
&lt;/p&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Telegraph, 7 March, 2014, http://www.telegraphindia.com/1140307/jsp/frontpage/story_18054877.jsp#.Uxkpwc5fQrY&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;cheap-medicine-myth-busted-gs-mudur-24447&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 24447,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 24268
$metaTitle = &#039;LATEST NEWS UPDATES | Cheap medicine myth busted -GS Mudur&#039;
$metaKeywords = &#039;medicines,Public Health,Health&#039;
$metaDesc = &#039;
-The Telegraph



New Delhi: The rules for price caps on 348 medicines imposed by the central government last year provide drug companies &amp;quot;escape routes&amp;quot; and promise little relief to consumers, a report released today has warned.


The report from the Public Health...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-The Telegraph&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;br /&gt;&lt;em&gt;New Delhi: &lt;/em&gt;The rules for price caps on 348 medicines imposed by the central government last year provide drug companies &amp;quot;escape routes&amp;quot; and promise little relief to consumers, a report released today has warned.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The report from the Public Health Foundation of India (PHFI), an academic institution, has also cautioned that the Drug Price Control Order (DPCO) rules will encourage the growth of irrational combinations of drugs that remain outside price control.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;PHFI researchers had in November last year presented preliminary results of their study at a conference, indicating that the DPCO covers drugs that account for only 17 per cent of the annual domestic sales worth Rs 72,000 crore.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The new report, described as a comprehensive analysis of the DPCO, has estimated that absolute decrease in the money spent on drugs in India is less than 2 per cent of baseline sales before the price caps came into effect.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;The price control rules do not seem to be the result of genuine intentions to provide relief to consumers,&amp;quot; said Malini Aisola, a research associate and health policy analyst at the PHFI, and one of the authors of the report.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The PHFI analysis has found that 18 of the top 20 new drug formulations - ranging from anti-diabetes and anti-cancer medications to vitamins - introduced by pharmaceutical companies in India over the past two years are outside price control.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The top-selling new brand, based on 2013 data from the pharmaceuticals industry, was a fixed dose combination of sitagliptin and metformin, used to treat diabetes, but outside price control. Examples of other drugs outside price control are those used to treat cancers, formulations containing vitamin D and calcium, a drug used to treat skin warts and drugs against HIV.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;We expect this trend to only grow - companies are likely to migrate to formulations not covered by the DPCO,&amp;quot; Aisola said. &amp;quot;The meagre 2 per cent relief that consumers seem to be getting now could shrink even more.&amp;quot;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;A network of health activists called the All India Drug Action Network has challenged the DPCO in the Supreme Court, contending that price caps should be imposed by taking into account the actual production costs of drugs instead of market prices as the DPCO does.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Sections of the pharmaceutical industry and government officials favouring the current form of the DPCO had said in the past that a shift to price caps based on actual production costs would hurt the pharmaceutical industry.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The PHFI report has also cautioned that the DPCO &amp;quot;paradoxically&amp;quot; punishes drug companies that have priced their products below price caps by forcing them to freeze their prices.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;This seems designed to kill the small and medium pharma industry,&amp;quot; said Aisola. &amp;quot;These rules punish those who charge less than the ceiling prices. Small companies often don&#039;t have deep pockets and could be badly hurt by increases in raw material prices or currency fluctuations.&amp;quot;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;There is nothing surprising,&amp;quot; said Chandra Gulhati, editor of the Monthly Index of Medical Specialities, India. &amp;quot;But I don&#039;t think the report&#039;s release has been timed well,&amp;quot; said Gulhati. &amp;quot;Who in the government is going to listen to this at this point of time?&amp;quot; &lt;/p&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/cheap-medicine-myth-busted-gs-mudur-24447.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | Cheap medicine myth busted -GS Mudur | Im4change.org</title>
    <meta name="description" content="
-The Telegraph



New Delhi: The rules for price caps on 348 medicines imposed by the central government last year provide drug companies &quot;escape routes&quot; and promise little relief to consumers, a report released today has warned.


The report from the Public Health..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>Cheap medicine myth busted -GS Mudur</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-The Telegraph</div><p align="justify"><br /><em>New Delhi: </em>The rules for price caps on 348 medicines imposed by the central government last year provide drug companies &quot;escape routes&quot; and promise little relief to consumers, a report released today has warned.</p><p align="justify">The report from the Public Health Foundation of India (PHFI), an academic institution, has also cautioned that the Drug Price Control Order (DPCO) rules will encourage the growth of irrational combinations of drugs that remain outside price control.</p><p align="justify">PHFI researchers had in November last year presented preliminary results of their study at a conference, indicating that the DPCO covers drugs that account for only 17 per cent of the annual domestic sales worth Rs 72,000 crore.</p><p align="justify">The new report, described as a comprehensive analysis of the DPCO, has estimated that absolute decrease in the money spent on drugs in India is less than 2 per cent of baseline sales before the price caps came into effect.</p><p align="justify">&quot;The price control rules do not seem to be the result of genuine intentions to provide relief to consumers,&quot; said Malini Aisola, a research associate and health policy analyst at the PHFI, and one of the authors of the report.</p><p align="justify">The PHFI analysis has found that 18 of the top 20 new drug formulations - ranging from anti-diabetes and anti-cancer medications to vitamins - introduced by pharmaceutical companies in India over the past two years are outside price control.</p><p align="justify">The top-selling new brand, based on 2013 data from the pharmaceuticals industry, was a fixed dose combination of sitagliptin and metformin, used to treat diabetes, but outside price control. Examples of other drugs outside price control are those used to treat cancers, formulations containing vitamin D and calcium, a drug used to treat skin warts and drugs against HIV.</p><p align="justify">&quot;We expect this trend to only grow - companies are likely to migrate to formulations not covered by the DPCO,&quot; Aisola said. &quot;The meagre 2 per cent relief that consumers seem to be getting now could shrink even more.&quot;</p><p align="justify">A network of health activists called the All India Drug Action Network has challenged the DPCO in the Supreme Court, contending that price caps should be imposed by taking into account the actual production costs of drugs instead of market prices as the DPCO does.</p><p align="justify">Sections of the pharmaceutical industry and government officials favouring the current form of the DPCO had said in the past that a shift to price caps based on actual production costs would hurt the pharmaceutical industry.</p><p align="justify">The PHFI report has also cautioned that the DPCO &quot;paradoxically&quot; punishes drug companies that have priced their products below price caps by forcing them to freeze their prices.</p><p align="justify">&quot;This seems designed to kill the small and medium pharma industry,&quot; said Aisola. &quot;These rules punish those who charge less than the ceiling prices. Small companies often don't have deep pockets and could be badly hurt by increases in raw material prices or currency fluctuations.&quot;</p><p align="justify">&quot;There is nothing surprising,&quot; said Chandra Gulhati, editor of the Monthly Index of Medical Specialities, India. &quot;But I don't think the report's release has been timed well,&quot; said Gulhati. &quot;Who in the government is going to listen to this at this point of time?&quot; </p>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$cookies = []
$values = [
	(int) 0 => 'text/html; charset=UTF-8'
]
$name = 'Content-Type'
$first = true
$value = 'text/html; charset=UTF-8'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitHeaders() - CORE/src/Http/ResponseEmitter.php, line 181
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 55
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

<head>

    <link rel="canonical" href="<?php echo Configure::read('SITE_URL'); ?><?php echo $urlPrefix;?><?php echo $article_current->category->slug; ?>/<?php echo $article_current->seo_url; ?>.html"/>

    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>

$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp'
$dataForView = [
	'article_current' => object(App\Model\Entity\Article) {

		'id' => (int) 24268,
		'title' => 'Cheap medicine myth busted -GS Mudur',
		'subheading' => '',
		'description' => '<div align="justify">
-The Telegraph
</div>
<p align="justify">
<br />
<em>New Delhi: </em>The rules for price caps on 348 medicines imposed by the central government last year provide drug companies &quot;escape routes&quot; and promise little relief to consumers, a report released today has warned.
</p>
<p align="justify">
The report from the Public Health Foundation of India (PHFI), an academic institution, has also cautioned that the Drug Price Control Order (DPCO) rules will encourage the growth of irrational combinations of drugs that remain outside price control.
</p>
<p align="justify">
PHFI researchers had in November last year presented preliminary results of their study at a conference, indicating that the DPCO covers drugs that account for only 17 per cent of the annual domestic sales worth Rs 72,000 crore.
</p>
<p align="justify">
The new report, described as a comprehensive analysis of the DPCO, has estimated that absolute decrease in the money spent on drugs in India is less than 2 per cent of baseline sales before the price caps came into effect.
</p>
<p align="justify">
&quot;The price control rules do not seem to be the result of genuine intentions to provide relief to consumers,&quot; said Malini Aisola, a research associate and health policy analyst at the PHFI, and one of the authors of the report.
</p>
<p align="justify">
The PHFI analysis has found that 18 of the top 20 new drug formulations - ranging from anti-diabetes and anti-cancer medications to vitamins - introduced by pharmaceutical companies in India over the past two years are outside price control.
</p>
<p align="justify">
The top-selling new brand, based on 2013 data from the pharmaceuticals industry, was a fixed dose combination of sitagliptin and metformin, used to treat diabetes, but outside price control. Examples of other drugs outside price control are those used to treat cancers, formulations containing vitamin D and calcium, a drug used to treat skin warts and drugs against HIV.
</p>
<p align="justify">
&quot;We expect this trend to only grow - companies are likely to migrate to formulations not covered by the DPCO,&quot; Aisola said. &quot;The meagre 2 per cent relief that consumers seem to be getting now could shrink even more.&quot;
</p>
<p align="justify">
A network of health activists called the All India Drug Action Network has challenged the DPCO in the Supreme Court, contending that price caps should be imposed by taking into account the actual production costs of drugs instead of market prices as the DPCO does.
</p>
<p align="justify">
Sections of the pharmaceutical industry and government officials favouring the current form of the DPCO had said in the past that a shift to price caps based on actual production costs would hurt the pharmaceutical industry.
</p>
<p align="justify">
The PHFI report has also cautioned that the DPCO &quot;paradoxically&quot; punishes drug companies that have priced their products below price caps by forcing them to freeze their prices.
</p>
<p align="justify">
&quot;This seems designed to kill the small and medium pharma industry,&quot; said Aisola. &quot;These rules punish those who charge less than the ceiling prices. Small companies often don't have deep pockets and could be badly hurt by increases in raw material prices or currency fluctuations.&quot;
</p>
<p align="justify">
&quot;There is nothing surprising,&quot; said Chandra Gulhati, editor of the Monthly Index of Medical Specialities, India. &quot;But I don't think the report's release has been timed well,&quot; said Gulhati. &quot;Who in the government is going to listen to this at this point of time?&quot; 
</p>',
		'credit_writer' => 'The Telegraph, 7 March, 2014, http://www.telegraphindia.com/1140307/jsp/frontpage/story_18054877.jsp#.Uxkpwc5fQrY',
		'article_img' => '',
		'article_img_thumb' => '',
		'status' => (int) 1,
		'show_on_home' => (int) 1,
		'lang' => 'EN',
		'category_id' => (int) 16,
		'tag_keyword' => '',
		'seo_url' => 'cheap-medicine-myth-busted-gs-mudur-24447',
		'meta_title' => null,
		'meta_keywords' => null,
		'meta_description' => null,
		'noindex' => (int) 0,
		'publish_date' => object(Cake\I18n\FrozenDate) {},
		'most_visit_section_id' => null,
		'article_big_img' => null,
		'liveid' => (int) 24447,
		'created' => object(Cake\I18n\FrozenTime) {},
		'modified' => object(Cake\I18n\FrozenTime) {},
		'edate' => '',
		'tags' => [
			[maximum depth reached]
		],
		'category' => object(App\Model\Entity\Category) {},
		'[new]' => false,
		'[accessible]' => [
			[maximum depth reached]
		],
		'[dirty]' => [[maximum depth reached]],
		'[original]' => [[maximum depth reached]],
		'[virtual]' => [[maximum depth reached]],
		'[hasErrors]' => false,
		'[errors]' => [[maximum depth reached]],
		'[invalid]' => [[maximum depth reached]],
		'[repository]' => 'Articles'
	
	},
	'articleid' => (int) 24268,
	'metaTitle' => 'LATEST NEWS UPDATES | Cheap medicine myth busted -GS Mudur',
	'metaKeywords' => 'medicines,Public Health,Health',
	'metaDesc' => '
-The Telegraph



New Delhi: The rules for price caps on 348 medicines imposed by the central government last year provide drug companies &quot;escape routes&quot; and promise little relief to consumers, a report released today has warned.


The report from the Public Health...',
	'disp' => '<div align="justify">-The Telegraph</div><p align="justify"><br /><em>New Delhi: </em>The rules for price caps on 348 medicines imposed by the central government last year provide drug companies &quot;escape routes&quot; and promise little relief to consumers, a report released today has warned.</p><p align="justify">The report from the Public Health Foundation of India (PHFI), an academic institution, has also cautioned that the Drug Price Control Order (DPCO) rules will encourage the growth of irrational combinations of drugs that remain outside price control.</p><p align="justify">PHFI researchers had in November last year presented preliminary results of their study at a conference, indicating that the DPCO covers drugs that account for only 17 per cent of the annual domestic sales worth Rs 72,000 crore.</p><p align="justify">The new report, described as a comprehensive analysis of the DPCO, has estimated that absolute decrease in the money spent on drugs in India is less than 2 per cent of baseline sales before the price caps came into effect.</p><p align="justify">&quot;The price control rules do not seem to be the result of genuine intentions to provide relief to consumers,&quot; said Malini Aisola, a research associate and health policy analyst at the PHFI, and one of the authors of the report.</p><p align="justify">The PHFI analysis has found that 18 of the top 20 new drug formulations - ranging from anti-diabetes and anti-cancer medications to vitamins - introduced by pharmaceutical companies in India over the past two years are outside price control.</p><p align="justify">The top-selling new brand, based on 2013 data from the pharmaceuticals industry, was a fixed dose combination of sitagliptin and metformin, used to treat diabetes, but outside price control. Examples of other drugs outside price control are those used to treat cancers, formulations containing vitamin D and calcium, a drug used to treat skin warts and drugs against HIV.</p><p align="justify">&quot;We expect this trend to only grow - companies are likely to migrate to formulations not covered by the DPCO,&quot; Aisola said. &quot;The meagre 2 per cent relief that consumers seem to be getting now could shrink even more.&quot;</p><p align="justify">A network of health activists called the All India Drug Action Network has challenged the DPCO in the Supreme Court, contending that price caps should be imposed by taking into account the actual production costs of drugs instead of market prices as the DPCO does.</p><p align="justify">Sections of the pharmaceutical industry and government officials favouring the current form of the DPCO had said in the past that a shift to price caps based on actual production costs would hurt the pharmaceutical industry.</p><p align="justify">The PHFI report has also cautioned that the DPCO &quot;paradoxically&quot; punishes drug companies that have priced their products below price caps by forcing them to freeze their prices.</p><p align="justify">&quot;This seems designed to kill the small and medium pharma industry,&quot; said Aisola. &quot;These rules punish those who charge less than the ceiling prices. Small companies often don't have deep pockets and could be badly hurt by increases in raw material prices or currency fluctuations.&quot;</p><p align="justify">&quot;There is nothing surprising,&quot; said Chandra Gulhati, editor of the Monthly Index of Medical Specialities, India. &quot;But I don't think the report's release has been timed well,&quot; said Gulhati. &quot;Who in the government is going to listen to this at this point of time?&quot; </p>',
	'lang' => 'English',
	'SITE_URL' => 'https://im4change.in/',
	'site_title' => 'im4change',
	'adminprix' => 'admin'
]
$article_current = object(App\Model\Entity\Article) {

	'id' => (int) 24268,
	'title' => 'Cheap medicine myth busted -GS Mudur',
	'subheading' => '',
	'description' => '<div align="justify">
-The Telegraph
</div>
<p align="justify">
<br />
<em>New Delhi: </em>The rules for price caps on 348 medicines imposed by the central government last year provide drug companies &quot;escape routes&quot; and promise little relief to consumers, a report released today has warned.
</p>
<p align="justify">
The report from the Public Health Foundation of India (PHFI), an academic institution, has also cautioned that the Drug Price Control Order (DPCO) rules will encourage the growth of irrational combinations of drugs that remain outside price control.
</p>
<p align="justify">
PHFI researchers had in November last year presented preliminary results of their study at a conference, indicating that the DPCO covers drugs that account for only 17 per cent of the annual domestic sales worth Rs 72,000 crore.
</p>
<p align="justify">
The new report, described as a comprehensive analysis of the DPCO, has estimated that absolute decrease in the money spent on drugs in India is less than 2 per cent of baseline sales before the price caps came into effect.
</p>
<p align="justify">
&quot;The price control rules do not seem to be the result of genuine intentions to provide relief to consumers,&quot; said Malini Aisola, a research associate and health policy analyst at the PHFI, and one of the authors of the report.
</p>
<p align="justify">
The PHFI analysis has found that 18 of the top 20 new drug formulations - ranging from anti-diabetes and anti-cancer medications to vitamins - introduced by pharmaceutical companies in India over the past two years are outside price control.
</p>
<p align="justify">
The top-selling new brand, based on 2013 data from the pharmaceuticals industry, was a fixed dose combination of sitagliptin and metformin, used to treat diabetes, but outside price control. Examples of other drugs outside price control are those used to treat cancers, formulations containing vitamin D and calcium, a drug used to treat skin warts and drugs against HIV.
</p>
<p align="justify">
&quot;We expect this trend to only grow - companies are likely to migrate to formulations not covered by the DPCO,&quot; Aisola said. &quot;The meagre 2 per cent relief that consumers seem to be getting now could shrink even more.&quot;
</p>
<p align="justify">
A network of health activists called the All India Drug Action Network has challenged the DPCO in the Supreme Court, contending that price caps should be imposed by taking into account the actual production costs of drugs instead of market prices as the DPCO does.
</p>
<p align="justify">
Sections of the pharmaceutical industry and government officials favouring the current form of the DPCO had said in the past that a shift to price caps based on actual production costs would hurt the pharmaceutical industry.
</p>
<p align="justify">
The PHFI report has also cautioned that the DPCO &quot;paradoxically&quot; punishes drug companies that have priced their products below price caps by forcing them to freeze their prices.
</p>
<p align="justify">
&quot;This seems designed to kill the small and medium pharma industry,&quot; said Aisola. &quot;These rules punish those who charge less than the ceiling prices. Small companies often don't have deep pockets and could be badly hurt by increases in raw material prices or currency fluctuations.&quot;
</p>
<p align="justify">
&quot;There is nothing surprising,&quot; said Chandra Gulhati, editor of the Monthly Index of Medical Specialities, India. &quot;But I don't think the report's release has been timed well,&quot; said Gulhati. &quot;Who in the government is going to listen to this at this point of time?&quot; 
</p>',
	'credit_writer' => 'The Telegraph, 7 March, 2014, http://www.telegraphindia.com/1140307/jsp/frontpage/story_18054877.jsp#.Uxkpwc5fQrY',
	'article_img' => '',
	'article_img_thumb' => '',
	'status' => (int) 1,
	'show_on_home' => (int) 1,
	'lang' => 'EN',
	'category_id' => (int) 16,
	'tag_keyword' => '',
	'seo_url' => 'cheap-medicine-myth-busted-gs-mudur-24447',
	'meta_title' => null,
	'meta_keywords' => null,
	'meta_description' => null,
	'noindex' => (int) 0,
	'publish_date' => object(Cake\I18n\FrozenDate) {},
	'most_visit_section_id' => null,
	'article_big_img' => null,
	'liveid' => (int) 24447,
	'created' => object(Cake\I18n\FrozenTime) {},
	'modified' => object(Cake\I18n\FrozenTime) {},
	'edate' => '',
	'tags' => [
		(int) 0 => object(Cake\ORM\Entity) {},
		(int) 1 => object(Cake\ORM\Entity) {},
		(int) 2 => object(Cake\ORM\Entity) {}
	],
	'category' => object(App\Model\Entity\Category) {},
	'[new]' => false,
	'[accessible]' => [
		'*' => true,
		'id' => false
	],
	'[dirty]' => [],
	'[original]' => [],
	'[virtual]' => [],
	'[hasErrors]' => false,
	'[errors]' => [],
	'[invalid]' => [],
	'[repository]' => 'Articles'

}
$articleid = (int) 24268
$metaTitle = 'LATEST NEWS UPDATES | Cheap medicine myth busted -GS Mudur'
$metaKeywords = 'medicines,Public Health,Health'
$metaDesc = '
-The Telegraph



New Delhi: The rules for price caps on 348 medicines imposed by the central government last year provide drug companies &quot;escape routes&quot; and promise little relief to consumers, a report released today has warned.


The report from the Public Health...'
$disp = '<div align="justify">-The Telegraph</div><p align="justify"><br /><em>New Delhi: </em>The rules for price caps on 348 medicines imposed by the central government last year provide drug companies &quot;escape routes&quot; and promise little relief to consumers, a report released today has warned.</p><p align="justify">The report from the Public Health Foundation of India (PHFI), an academic institution, has also cautioned that the Drug Price Control Order (DPCO) rules will encourage the growth of irrational combinations of drugs that remain outside price control.</p><p align="justify">PHFI researchers had in November last year presented preliminary results of their study at a conference, indicating that the DPCO covers drugs that account for only 17 per cent of the annual domestic sales worth Rs 72,000 crore.</p><p align="justify">The new report, described as a comprehensive analysis of the DPCO, has estimated that absolute decrease in the money spent on drugs in India is less than 2 per cent of baseline sales before the price caps came into effect.</p><p align="justify">&quot;The price control rules do not seem to be the result of genuine intentions to provide relief to consumers,&quot; said Malini Aisola, a research associate and health policy analyst at the PHFI, and one of the authors of the report.</p><p align="justify">The PHFI analysis has found that 18 of the top 20 new drug formulations - ranging from anti-diabetes and anti-cancer medications to vitamins - introduced by pharmaceutical companies in India over the past two years are outside price control.</p><p align="justify">The top-selling new brand, based on 2013 data from the pharmaceuticals industry, was a fixed dose combination of sitagliptin and metformin, used to treat diabetes, but outside price control. Examples of other drugs outside price control are those used to treat cancers, formulations containing vitamin D and calcium, a drug used to treat skin warts and drugs against HIV.</p><p align="justify">&quot;We expect this trend to only grow - companies are likely to migrate to formulations not covered by the DPCO,&quot; Aisola said. &quot;The meagre 2 per cent relief that consumers seem to be getting now could shrink even more.&quot;</p><p align="justify">A network of health activists called the All India Drug Action Network has challenged the DPCO in the Supreme Court, contending that price caps should be imposed by taking into account the actual production costs of drugs instead of market prices as the DPCO does.</p><p align="justify">Sections of the pharmaceutical industry and government officials favouring the current form of the DPCO had said in the past that a shift to price caps based on actual production costs would hurt the pharmaceutical industry.</p><p align="justify">The PHFI report has also cautioned that the DPCO &quot;paradoxically&quot; punishes drug companies that have priced their products below price caps by forcing them to freeze their prices.</p><p align="justify">&quot;This seems designed to kill the small and medium pharma industry,&quot; said Aisola. &quot;These rules punish those who charge less than the ceiling prices. Small companies often don't have deep pockets and could be badly hurt by increases in raw material prices or currency fluctuations.&quot;</p><p align="justify">&quot;There is nothing surprising,&quot; said Chandra Gulhati, editor of the Monthly Index of Medical Specialities, India. &quot;But I don't think the report's release has been timed well,&quot; said Gulhati. &quot;Who in the government is going to listen to this at this point of time?&quot; </p>'
$lang = 'English'
$SITE_URL = 'https://im4change.in/'
$site_title = 'im4change'
$adminprix = 'admin'

include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51

Cheap medicine myth busted -GS Mudur

-The Telegraph New Delhi: The rules for price caps on 348 medicines imposed by the central government last year provide drug companies "escape routes" and promise little relief to consumers, a report released today has warned. The report from the Public Health Foundation of India (PHFI), an academic institution, has also cautioned that the Drug Price Control Order (DPCO) rules will encourage the growth of irrational combinations of drugs that remain outside price control. PHFI researchers had in November last year presented preliminary results of their study at a conference, indicating that the DPCO covers drugs that account for only 17 per cent of the annual domestic sales worth Rs 72,000 crore. The new report, described as a comprehensive analysis of the DPCO, has estimated that absolute decrease in the money spent on drugs in India is less than 2 per cent of baseline sales before the price caps came into effect. "The price control rules do not seem to be the result of genuine intentions to provide relief to consumers," said Malini Aisola, a research associate and health policy analyst at the PHFI, and one of the authors of the report. The PHFI analysis has found that 18 of the top 20 new drug formulations - ranging from anti-diabetes and anti-cancer medications to vitamins - introduced by pharmaceutical companies in India over the past two years are outside price control. The top-selling new brand, based on 2013 data from the pharmaceuticals industry, was a fixed dose combination of sitagliptin and metformin, used to treat diabetes, but outside price control. Examples of other drugs outside price control are those used to treat cancers, formulations containing vitamin D and calcium, a drug used to treat skin warts and drugs against HIV. "We expect this trend to only grow - companies are likely to migrate to formulations not covered by the DPCO," Aisola said. "The meagre 2 per cent relief that consumers seem to be getting now could shrink even more." A network of health activists called the All India Drug Action Network has challenged the DPCO in the Supreme Court, contending that price caps should be imposed by taking into account the actual production costs of drugs instead of market prices as the DPCO does. Sections of the pharmaceutical industry and government officials favouring the current form of the DPCO had said in the past that a shift to price caps based on actual production costs would hurt the pharmaceutical industry. The PHFI report has also cautioned that the DPCO "paradoxically" punishes drug companies that have priced their products below price caps by forcing them to freeze their prices. "This seems designed to kill the small and medium pharma industry," said Aisola. "These rules punish those who charge less than the ceiling prices. Small companies often don't have deep pockets and could be badly hurt by increases in raw material prices or currency fluctuations." "There is nothing surprising," said Chandra Gulhati, editor of the Monthly Index of Medical Specialities, India. "But I don't think the report's release has been timed well," said Gulhati. "Who in the government is going to listen to this at this point of time?"